Calgary-based research moves from the lab to the marketplace
Epimeron Inc. (“Epimeron”), a Calgary-based biotechnology company, today announced that it has licensed certain of its proprietary technologies to a US-based company. The terms of the agreement were not disclosed. Epimeron President and CEO Dr. Joseph Tucker stated, “We are pleased with the validation of our technology and business approach that entering into this agreement […]
Calgary-based research moves from the lab to the marketplace Read More »